Evolus, Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
EOLS Nasdaq 2830 www.evolus.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Evolus, Inc.

When Can We Expect A Profit From Evolus, Inc. (NASDAQ:EOLS)? - Jun 20th, 2025 6:31 am
Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Jun 13th, 2025 2:05 pm
Evolysse™ Recognized in 2025 Shape Skin Awards - Jun 10th, 2025 6:00 am
Evolus Announces Departure of its Chief Financial Officer - May 27th, 2025 2:15 pm
Evolus Announces Publication of U.S. Pivotal Study for Evolysse™ Form and Evolysse™ Smooth Injectable Hyaluronic Acid Gels - May 22nd, 2025 6:00 am
Evolus, Inc. (EOLS): A Bull Case Theory - May 13th, 2025 7:51 am
Evolus, Inc. (NASDAQ:EOLS) First-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year - May 10th, 2025 7:24 am
Evolus First Quarter 2025 Earnings: Misses Expectations - May 9th, 2025 6:24 am
Evolus Inc (EOLS) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amid Market Challenges - May 8th, 2025 1:28 am
Evolus, Inc. (EOLS) Reports Q1 Loss, Misses Revenue Estimates - May 7th, 2025 4:55 pm
Evolus Reports First Quarter 2025 Results - May 7th, 2025 2:05 pm
Evolus Strengthens Balance Sheet with Refinancing; Reducing Cost of Capital and Expanding Financial Flexibility - May 5th, 2025 2:05 pm
Will Evolus, Inc. (EOLS) Report Negative Earnings Next Week? What You Should Know - Apr 30th, 2025 8:01 am
Evolus to Report First Quarter Financial Results on May 7, 2025 - Apr 23rd, 2025 6:00 am
Evolus Announces Commercial Launch of Evolysse™ - Apr 16th, 2025 6:00 am
Evolus Launches "Drop the F Word" Campaign in Advance of the Commercial Launch of Evolysse™ Injectable Hyaluronic Acid Gels - Apr 15th, 2025 6:00 am
Evolus to Participate in The Needham 24th Annual Virtual Healthcare Conference - Mar 25th, 2025 6:00 am
Investing in Evolus (NASDAQ:EOLS) five years ago would have delivered you a 216% gain - Mar 23rd, 2025 7:50 am
Mixue Group's Splashy Debut, Kroger's Change, Stuffed Crust Pizza, and Med Spas - Mar 10th, 2025 2:53 pm
Evolus Inc (EOLS) Q4 2024 Earnings Call Highlights: Record Revenue Growth and Strategic Market ... - Mar 5th, 2025 12:09 am